A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV This is an open Phase I study of a candidate TB vaccine, MVA85A, in healthy subjects who are infected with HIV. It is designed to study the safety and immunogenicity of the vaccine.

• Country Senegal
• organs None
• Specialty None

Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks Primary objective: to demonstrate the non-inferiority of PCR adjusted adequate clinical and parasitological response at D28 of artesunate + amiodaquine versus artemether + lumefantrine, ba...

• Country Senegal
• organs None
• Specialty None

Characterizing the Gut Microbiota Alteration Associated With Severe Acute Malnutrition The investigators performed two case-control studies in Niger and Senegal analysing fecal microbiota to characterize the specificity of the gut microbiota alteration associated with severe...

• Country Niger, Senegal
• organs None
• Specialty None

Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance Primary Objective: To demonstrate the non-inferiority, in terms of clinical and parasitological efficacy on Day 14, of administration of Arsucam® as a single daily intake versus two daily...

• Country Cameroon, Senegal
• organs None
• Specialty None

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal The purpose of this study is to determine the safety and effectiveness of the anti-HIV drugs efavirenz and lamivudine/zidovudine given to treatment-naive HIV-infected people in Dakar, Sene...

• Country Senegal
• organs None
• Specialty None